These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 28001263

  • 1. Current management of non-alcoholic fatty liver disease.
    Lisboa QC, Costa SM, Couto CA.
    Rev Assoc Med Bras (1992); 2016 Dec; 62(9):872-878. PubMed ID: 28001263
    [Abstract] [Full Text] [Related]

  • 2. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Golabi P, Bush H, Younossi ZM.
    Clin Liver Dis; 2017 Nov; 21(4):739-753. PubMed ID: 28987260
    [Abstract] [Full Text] [Related]

  • 3. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S, Kienbacher C, Halilbasic E, Rechling C, Kazemi-Shirazi L, Hofer H, Munda P, Trauner M.
    Dig Dis; 2015 Nov; 33(4):598-607. PubMed ID: 26159280
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Current treatment options for nonalcoholic fatty liver disease.
    Shetty A, Syn WK.
    Curr Opin Gastroenterol; 2019 May; 35(3):168-176. PubMed ID: 30844893
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Position statement on the diagnosis and management of non-alcoholic fatty liver disease.
    Alswat KA, Fallatah HI, Al-Judaibi B, Elsiesy HA, Al-Hamoudi WK, Qutub AN, Alturaify N, Al-Osaimi A.
    Saudi Med J; 2019 Jun; 40(6):531-540. PubMed ID: 31219486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A, Pár G.
    Orv Hetil; 2016 Jun 19; 157(25):987-94. PubMed ID: 27287838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nonalcoholic steatohepatitis, obesity, and cardiac dysfunction.
    Mathews SE, Kumar RB, Shukla AP.
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct 19; 25(5):315-320. PubMed ID: 30074500
    [Abstract] [Full Text] [Related]

  • 17. Understanding nutritional interventions and physical exercise in non-alcoholic fatty liver disease.
    Ordonez R, Carbajo-Pescador S, Mauriz JL, Gonzalez-Gallego J.
    Curr Mol Med; 2015 Oct 19; 15(1):3-26. PubMed ID: 25601465
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-alcoholic fatty liver disease.
    Smith BW, Adams LA.
    Crit Rev Clin Lab Sci; 2011 Oct 19; 48(3):97-113. PubMed ID: 21875310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.